本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Krystal Biotech Inc.

264.06
-4.4800-1.67%
盤後264.060.00000.00%19:26 EDT
成交量:22.47萬
成交額:5,929.29萬
市值:77.73億
市盈率:38.61
高:267.41
開:266.92
低:262.02
收:268.54
52周最高:298.30
52周最低:122.80
股本:2,943.57萬
流通股本:2,297.99萬
量比:0.89
換手率:0.98%
股息:- -
股息率:- -
每股收益(TTM):6.84
每股收益(LYR):6.84
淨資產收益率:18.91%
總資產收益率:8.44%
市淨率:6.37
市盈率(LYR):38.61

資料載入中...

2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities